Core Viewpoint - The article emphasizes the importance of timing and sustainability in short-term investing, highlighting that a solid trend can lead to successful investments if supported by strong fundamentals and positive earnings revisions [1][2]. Group 1: Stock Performance - Swire Pacific (SWRAY) has shown a solid price increase of 7.5% over the past 12 weeks, indicating investor confidence in its potential upside [4]. - The stock has also increased by 6.5% over the last four weeks, suggesting that the upward trend is still intact [5]. - SWRAY is currently trading at 88.5% of its 52-week high-low range, indicating a potential breakout opportunity [5]. Group 2: Fundamental Strength - SWRAY holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [7]. Group 3: Investment Strategy - The "Recent Price Strength" screen is a useful tool for identifying stocks with sufficient fundamental strength to maintain their upward trends [3]. - The article suggests that investors should consider other stocks that pass through this screening process, as well as explore various Zacks Premium Screens tailored to different investing styles [8].

release the damn files. Let the the light of day um u let the sun shine through and that's the best way to get past it. It's not crazy advice.Republican Senator Tom Tillis calling to release the damn files because the Epstein issue is not going to die. And of course, just after hours after he said that, the Wall Street Journal comes out with a new report. NBC News has not confirmed saying that Donald Trump's name appeared multiple times in the Epstein files, according to senior administration officials. Now ...

Qatar confirms it will bid for the 2036 Summer Olympics, trying to become the first Middle Eastern nation to host one of the world’s biggest sporting events https://t.co/gzoS20N7qb ...

Core Insights - Stock picking has proven to be highly profitable amid significant market volatility this year, with individual stocks outperforming the S&P 500, which has remained relatively flat [1] - Increased dispersion in stock performance is anticipated, which will benefit investors who actively trade [1] Group 1: Market Performance - The current market environment has rewarded stock pickers significantly, indicating a divergence in stock performance compared to the overall market index [1] - The S&P 500 has shown a flat performance, highlighting the potential for selective investment strategies to yield better returns [1] Group 2: Analyst Background - Gary Alexander possesses extensive experience in technology sectors, having worked on Wall Street and in Silicon Valley, which informs his insights into current industry trends [1] - His role as an adviser to seed-round startups provides him with a unique perspective on emerging themes within the technology industry [1]

Châtillon, France, July 22, 2025 DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), a clinical-stage biopharmaceutical company, today announced the appointment of James Briggs as its Chief Human Resources Officer, succeeding Caroline Daniere. An experienced human capital executive, James will lead key initiatives as DBV transitions from a development-stage biotechnology company to a potential c ...

New ETFs promise access to billionaire stock picks from Warren Buffett, Bill Ackman, and others—but experts say the real value might just be the branding. https://t.co/cAoTk8f35r ...

Why don't we start with your word of the day. Uh my word of the day is myopic. And what do we mean by myopic.Investors are being too myopic and they're looking at the day-to-day headlines and not looking at the big picture. This market is trading at all-time highs and no one's really talking about that. Everyone's worried about oh the tariffs this and the next deadline that.Uh coal play concerts now we're worried about. But um to me it's it's the future. And I think the financials are the perfect thing beca ...

Core Insights - Tesla's Cybertruck is experiencing declining demand, falling to third place in the electric pickup market behind Ford and General Motors [1][2] - The Cybertruck has seen its sales decline for three consecutive quarters, with only 4,306 units sold in Q2 2024 [2][9] - Ford's F-150 Lightning and GM's Hummer EV have also seen sales fluctuations, with the Hummer experiencing an increase in sales [3][9] Sales Performance - In Q2 2024, Ford led the electric pickup market, while Tesla's Cybertruck ranked fifth among all electric vehicles in the U.S. with 38,965 units sold [4] - The F-150 Lightning sold 33,510 units, ranking sixth, while the Hummer EV's sales increased to 4,508 units [4][9] - Tesla's "other" category, which includes the Cybertruck, saw a significant drop to 10,394 vehicles sold, the lowest since Q1 2023 [6] Production and Future Outlook - Tesla initially aimed for an annual production capacity of 250,000 Cybertrucks, but current sales trends suggest a potential reduction in production plans [4][7] - The company may shift focus towards better-selling vehicles and new growth initiatives, such as robotaxis [7] - Tesla's stock is currently trading at $321.65, down 15% year-to-date in 2025 [8]

Core Insights - BioAdaptives, Inc. is set to launch NeuroRush™, a nootropic designed to enhance cognitive performance and stress adaptability, with a full commercial release planned for August/September 2025 following successful test market results [1][3] Product Details - NeuroRush™ features a premium adaptogen-based formula that includes six clinically studied ingredients: Rhodiola Rosea, Ashwagandha, Bacopa Monnieri, Panax Ginseng, and Mucuna Pruriens, aimed at providing a balanced experience for high-functioning individuals [2] - The product will be available in two formulations: one with natural caffeine for fast-acting mental energy and a caffeine-free version for those sensitive to stimulants [2] Market Strategy - BioAdaptives plans to distribute NeuroRush™ through select online retailers, direct-to-consumer channels, and strategic health & wellness partners across the nation [4] - Initial consumer feedback indicates that NeuroRush™ is perceived as a high-performance solution that differentiates itself from conventional stimulant-based brain products [4] Company Overview - BioAdaptives, Inc. focuses on developing and marketing science-based natural health and wellness products, leveraging research in stem cell biology, adaptogens, and regenerative nutrition [5]

ETF Products - New ETFs offer exposure to stock selections of prominent billionaires like Warren Buffett and Bill Ackman [1] - The branding associated with these billionaire stock picks may be the primary value proposition of the ETFs [1] Expert Opinion - Experts suggest the real value of these ETFs might be in their branding rather than investment performance [1]